官方服务：
资源简介：
Complications and survival B/FEVAR.
应用场景：
创建时间：
2016-05-05
相关数据集
Aortic Stenosis Treatment Market Study by Transcatheter Aortic Valve Replacement, Surgical Aortic Valve Replacement, Balloon Valvuloplasty, Beta Blockers, and Cardiac Glycosides from 2024 to 2034
Worldwide revenue from aortic stenosis treatment solutions is expected to reach US$ 7.57 billion in 2024, as revealed in Fact.MR’s newly published market report. The global a
www.factmr.com2024-07-16 更新70
Primary venous patency of patients who underwent interposition graft reconstruction.
Primary venous patency of patients who underwent interposition graft reconstruction.
NIAID Data Ecosystem40
Supplementary Material for: Age-related outcomes of transcatheter aortic valve replacement in patients with pure severe aortic regurgitation
Abstract Background: Transcatheter aortic valve replacement (TAVR) has emerged as the recommended treatment for older patients with pure severe aortic regurgitation (PSAR). However, the efficacy of TA
Figshare2025-02-24 更新20
2024 欧洲心脏病学会（ESC）外周动脉和主动脉疾病管理指南
该指南首次将外周动脉疾病与主动脉疾病合并，更新和整合了2017年外周动脉疾病指南和2014年主动脉疾病指南，旨在为全身动脉疾病管理提供标准化建议，确保患者接受连贯、综合的诊断和治疗，从而改善预后。指南主要内容包括：（1）诊断与筛查：推荐使用非侵入性血管测试和成像进行PAAD诊断，踝肱指数应作为筛查和诊断外周动脉疾病（PAD）的初始诊断测试。（2）治疗策略： &nb
国家科技图书文献中心60
Mortality: TAVI versus medical therapy in surgically inoperable patients.
Mortality: TAVI versus medical therapy in surgically inoperable patients.
NIAID Data Ecosystem40
